Cargando…
Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments
Rheumatoid arthritis (RA) is a systemic immune disease characterized by synovial inflammation. Patients with RA commonly experience significant damage to their hand and foot joints, which can lead to joint deformities and even disability. Traditional treatments have several clinical drawbacks, inclu...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039584/ https://www.ncbi.nlm.nih.gov/pubmed/36964609 http://dx.doi.org/10.1186/s12951-023-01857-8 |